Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Marie-Elisabeth Sarciron is active.

Publication


Featured researches published by Marie-Elisabeth Sarciron.


Bioorganic & Medicinal Chemistry | 2003

Synthesis and antiprotozoal activity of naphthofuranquinones and naphthothiophenequinones containing a fused thiazole ring

Ricardo A. Tapia; Luz Alegría; Carlos D. Pessoa; Cristian O. Salas; Manuel Cortés; Jaime A. Valderrama; Marie-Elisabeth Sarciron; Félix Pautet; Nadia Walchshofer; Houda Fillion

The synthesis of tetracyclic quinones 10a,b, 14a,b, 19a,b and 20a,b is described. The preparations involve regioselective Diels-Alder reactions via trapping the thiazole o-quinodimethane 9 with several benzofuranquinones and benzothiophenequinones. The structure of the regioisomers was assigned through 2D NMR 1H-13C HMBC experiments performed on 10a and 14a. Compounds 10a,b, 14a as well as phenol 1 and the starting quinones 2, 5, 7 and 15 are evaluated against Leishmania sp., Toxoplasma gondii and THP-1 cells. Almost all the tested compounds exhibit significant antiprotozoal activities with lower cytotoxicities than the reference compounds. Among them, quinones 2 and 14a possess the best activities towards L. donovani and T. gondii with the lowest toxicities.


International Journal of Pharmaceutics | 2008

Study on the hydatid cyst membrane: permeation of model molecules and interactions with drug-loaded nanoparticles.

Tri Truong Cong; Vincent Faivre; Tien Thanh Nguyen; Hernan Heras; Fabrice Pirot; Nadia Walchshofer; Marie-Elisabeth Sarciron; Françoise Falson

The success of the chemotherapeutic treatment of hydatid disease is based upon the drug ability to operate on the germinal layer and on the protoscolices of the hydatid cyst interior at adequate concentrations for sufficient periods. The goal of this study was to evaluate the ability of the drug diffusion through the cyst membrane from sheep hydatid cysts and the increase of drug concentration in the cyst environment. In the first part of this work, the permeation behaviour through the hydatid cyst membrane was studied with five model molecules, having different molecular descriptors (logP, molecular weight, polar surface area ...) onto static Franz glass diffusion cells. A good correlation has been observed between the permeation coefficient and the partition coefficient, log P (r=0.951). In the second part, albendazole-loaded nanoparticles (about 300 nm) prepared by the emulsion solvent evaporation method have shown a sufficient entrapment efficiency (36.4 +/- 6.4%) to raise the apparent solubility of albendazole. The diffusion of drug from the nanoparticles across the hydatid cyst membrane was also improved compare to albendazole suspension. These results have shown the interest of the albendazole-loaded nanoparticles for the treatment of hydatid cysts in the future.


Comparative Biochemistry and Physiology B | 1995

Echinococcus granulosus, E. multilocularis and mammalian liver-type alkaline phosphatases: a comparative study

Philippe Lawton; Marie-Elisabeth Sarciron; Anne-Françoise Pétavy

The alkaline phosphatases (EC 3.1.3.1) from Echinococcus granulosus and E. multilocularis (Cestoda) were compared to each other and to a liver-type enzyme. The purified proteins (210 and 220 kDa, respectively) had a tetrameric structure composed of 4, 56/53 kDa subunits. Enzymatic removal of their N-linked sugar moieties abolished the differences in their apparent molecular weight under reducing conditions. After phase separation in Triton X-114, the E. multilocularis enzyme was the most amphiphilic, and treatment with PI-P1C reduced the amount of the parasite alkaline phosphatases that were in a hydrophobic form by about 50%. Both parasite enzymes were highly resistant to heat denaturation and insensitive to the inhibitors L-phenylalanine and L-leucine. In addition, L-homoarginine, levamisole and ZnCl2 can be used to differentiate the parasite and mammalian liver-type enzymes from each other. The Echinococcus alkaline phosphatases have original biochemical properties when compared to the mammalian liver-type enzyme.


International Journal of Pharmaceutics | 1993

Biological effects of a dipeptide methyl ester on Echinococcus multilocularis metacestodes in vivo

Nadia Walchshofer; Marie-Elisabeth Sarciron; Christine Arsac; Suzanne Walbaum; Joelle Paris; Anne-Françoise Pétavy

Abstract The biological effects of Phe-Phe-OMe (1) were evaluated in gerbils against the causative agent of alveolar echinococcosis, Echinococcus multilocularis . Morphological damage to the parasite was examined by transmission electron microscopy. Administration of ( 1 ) led to a considerable alteration of the laminated layer. Although a histoenzymatic study showed a decrease in alkaline phosphatase activity in the parasite, a precise mode of action for ( 1 ) cannot be proposed.


Veterinary Research Communications | 2006

Cystic hydatic disease in sheep: treatment with percutaneous aspiration and injection with dipeptide methyl ester.

Samia Lahmar; Marie-Elisabeth Sarciron; F. Ben Chehida; A. Hammou; H. A. Gharbi; Arnaud Ghérardi; J. Lahmar; A. Ghannay; A.F. Pétavy

An in vitro and in vivo study was conducted to show the effect of dipeptide methyl ester on the protoscolices of Echinococcus granulosus and in naturally infected sheep. Easily punctured cysts were located by ultrasonography. A PAIR and PAI method were performed bythe injection of dipeptide methyl ester into these cysts at a final concentration of 110 mmol/L. Follow-up was conducted monthly by ultrasonography. After injection of the compound, the sheep were sacrificed at different times from 6 to 17 weeks. The size and the morphological aspect of treated cysts were noted. Samples were collected for histologyand electron microscopy. In conclusion, these studies revealed significant and rapid detachment of the membrane of the treated cyst and alteration of the inner membrane in less than 5 min after injection of the drug, confirming the effect of the compound on the laminated layer of the parasite.


European Journal of Medicinal Chemistry | 1992

In vivo and in vitro effects of methacrylanilides and acetylcarboxanilide on alkaline phosphatase activity of Echinococcus multilocularis metacestodes

P Audin; Marie-Elisabeth Sarciron; Joelle Paris; Af Petavy

Abstract In our search for effective chemotherapy of alveolar hydatid disease we are investigating key enzymes of Echinococcus multilocularis metacestodes. Isatin (2,3-indolinedione) is well known as an inhibitor of alkaline phosphatase activity, and has been previously investigated. Acetylcarboxanilide, an ‘open drug’ of isatin and 2 methacrylanilides were evaluated for their ability to inhibit alkaline phosphatase activity of Echinococcus multilocularis metacestodes in vivo. These ‘open drugs’ are more efficient than isatin, and para-chloromethacrylanilide exhibits a strong selectivity for the parasite enzyme and is also effective in vitro. The results obtained with para-chloromethacrylanilide are promising.


Medical Molecular Morphology | 2005

Toxoplasma gondii: localization of purine nucleoside phosphorylase activity in vitro and in vivo by electron microscopy.

Arnaud Ghérardi; Simone Peyrol; Marie-Elisabeth Sarciron

Purine nucleoside phosphorylase (PNP, EC 2.4.2.1) activity was revealed by enzyme histochemistry in Toxoplasma gondii ME49 strain isolated from murine cerebral cysts and from in vitro cultivation. The activity of the enzyme was revealed by an insoluble electron-opaque precipitate of lead phosphate at the site of the reaction. In bradyzoites and tachyzoites of T. gondii, the enzyme activity could be observed only in the cytoplasm. In bradyzoites, one or two foci of important PNP activity were detected near the nucleus. In tachyzoites, an important PNP activity underlined the plasma membrane. For both bradyzoites and tachyzoites, localization neither in the nucleus nor in cytoplasmic organelles could be detected.


Current HIV Research | 2004

Prevalence of Toxoplasma Encephalitis in AIDS Patients Treated with Didanosine Hospitalised in a French Infectious Service

Marie-Elisabeth Sarciron; Arnaud Ghérardi; Chantal Delorme; Dominique Peyramond; Anne-Françoise Pétavy

In a previous work, we have showed in mice infected with an avirulent strain of Toxoplasma gondii and receiving a didanosine treatment, an important decrease of brain cysts. It is why, the purpose of this study was to investigate the effect of didanosine treatment on AIDS patients having developed Toxoplasma encephalitis. 60 patient reports were analyzed: 22 patients (group 1) did not received didanosine in their antiretroviral treatment and 38 (group 2) were treated with didanosine. The results showed that an antiretroviral therapy was prescribed for 93% of patients, 50% of them received only zidovudine and protease inhibitors were prescribed for 37%. The regimens given most frequently were those including zidovudine plus lamivudine or zidovudine plus indinavir. Among the group 1, 18% have had a relapse of Toxoplasma encephalitis. In the group 2, 37% of the patients suffered from one episode of TE while 16% have had two TE after the pause in their didanosine treatment, the maximum occurring between 4 and 24 months after the pause of didanosine. This study showed that didanosine seems to have an effect on cerebral cysts. Also, this work made a synthesis about the different treatment used in AIDS patients and the new molecules yet in development against T. gondii.


Veterinary Parasitology | 2007

Ultrasonographic screening for cystic echinococcosis in sheep in Tunisia.

Selma Lahmar; F. Ben Chéhida; A.F. Pétavy; A. Hammou; J. Lahmar; A. Ghannay; H. A. Gharbi; Marie-Elisabeth Sarciron


European Journal of Medicinal Chemistry | 2006

Synthesis and evaluation of antifungal activity of naphthoquinone derivatives.

Giaccomo Errante; Grazia La Motta; Catarina Lagana; Vierle Wittebolle; Marie-Elisabeth Sarciron; Roland Barret

Collaboration


Dive into the Marie-Elisabeth Sarciron's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

A. Hammou

Boston Children's Hospital

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Muriel Naciri

Institut national de la recherche agronomique

View shared research outputs
Top Co-Authors

Avatar

Roselyne Mancassola

Institut national de la recherche agronomique

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge